A maximally tolerated dose of panobinostat (15 mg/kg), produces a survival benefit only in NPAIC1 IDHmut glioma, whereas NPA1 IDHwt tumors show no response (Figure 7, A and B). The gene discussed is URB1; the disease is central nervous system cancer.